Coherus Biosciences Inc (NASDAQ:CHRS)

26.97
Delayed Data
As of Mar 26
 +2.42 / +9.86%
Today’s Change
12.27
Today|||52-Week Range
33.30
+65.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

--

--

--
Revenue and IncomeNet Revenues2.8M------
 
 
Depreciation And Amortization404.0K------
 
 
 
Operating ExpensesGross Income----------
General Expenses38.3M------
 
 
Research And Development31.3M------
 
 
Total Operating Expenses38.7M------
 
 
 
Non-Operating ExpensesOperating Income-36.0M------
 
 
Interest Expense On Debt5.3M------
 
 
Other Expenses-12.3M------
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.6M------
 
 
Net Income-53.6M------
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.6M------
 
 
Shares To Calculate EPS Diluted5.6M------
 
 
 
Earnings Per ShareEPS-$9.66------
 
 
EPS Diluted-$9.66------
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account